These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987 AND Clinical Outcome
9 results:

  • 1. Distinct mutation spectrum, clinical outcome and therapeutic responses of typical complex/monosomy karyotype acute myeloid leukemia carrying TP53 mutations.
    Leung GMK; Zhang C; Ng NKL; Yang N; Lam SSY; Au CH; Chan TL; Ma ESK; Tsui SP; Ip HW; So JCC; Ng MHL; Cheng KCK; Wong KF; Siu LLP; Yip SF; Lin SY; Lau JSM; Luk TH; Lee HKK; Lau CK; Kho B; Kwong YL; Leung AYH
    Am J Hematol; 2019 Jun; 94(6):650-657. PubMed ID: 30900772
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. clinical impact of SNP of P53 genes pathway on the adult AML patients.
    Abdel Hamid TM; El Gammal MM; Eibead GT; Saber MM; Abol Elazm OM
    Hematology; 2015 Jul; 20(6):328-35. PubMed ID: 25232917
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A three-gene signature and clinical outcome in esophageal squamous cell carcinoma.
    Sun LL; Wu JY; Wu ZY; Shen JH; Xu XE; Chen B; Wang SH; Li EM; Xu LY
    Int J Cancer; 2015 Mar; 136(6):E569-77. PubMed ID: 25220908
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. mdm2 SNP309 promoter polymorphism, an independent prognostic factor in chronic lymphocytic leukemia.
    Willander K; Ungerbäck J; Karlsson K; Fredrikson M; Söderkvist P; Linderholm M
    Eur J Haematol; 2010 Sep; 85(3):251-6. PubMed ID: 20491880
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Lack of association between the mdm2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukemia.
    Kaderi MA; Mansouri M; Zainuddin N; Cahill N; Gunnarsson R; Jansson M; Kimby E; Aleskog A; Lundin J; Glimelius B; Melbye M; Juliusson G; Jurlander J; Rosenquist R
    Leuk Res; 2010 Mar; 34(3):335-9. PubMed ID: 19573916
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. mdm2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.
    Gryshchenko I; Hofbauer S; Stoecher M; Daniel PT; Steurer M; Gaiger A; Eigenberger K; Greil R; Tinhofer I
    J Clin Oncol; 2008 May; 26(14):2252-7. PubMed ID: 18467716
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Nucleophosmin gene mutations in acute myeloid leukemia.
    Chen W; Rassidakis GZ; Medeiros LJ
    Arch Pathol Lab Med; 2006 Nov; 130(11):1687-92. PubMed ID: 17076533
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. p53 and mdm2 in mantle cell lymphoma in leukemic phase.
    Solenthaler M; Matutes E; Brito-Babapulle V; Morilla R; Catovsky D
    Haematologica; 2002 Nov; 87(11):1141-50. PubMed ID: 12414343
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
    Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M
    Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.